You are here
- Home
- Therapy Areas
- Gastrointestinal
AZD3355 Dose-escalation Study in Healthy Males
- Disease
- gastroesophageal reflux disease
- Drug Name
- AZD3355
- Generic Name
- AZD3355
- Sponsor
- AstraZeneca
- Drug Status
- Discontinued
- Phase
- I
- Start Date
- Sep 4, 2008
- Study Name
- D9120C00030
- Study Id
- D9120C00030
- ClinicalTrials.gov ID
- NCT00757419
- Recruiting Status
- Closed
- Protocol Status
- Not Available
- Report
-
Apr 2, 2009
- D9120C00030.pdf (505 KB)
